Ning Xu

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma

Weiquan Li, Xiaoping Zhang, Hongmei Yang, 2022, iScience.

Donor T cells for CAR T cell therapy

A. Dolnikov, M. Haber, R. Nordon, 2022, Biomarker research.

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

P. Gregory, M. Holmes, Kamola Saydaminova, 2015, Molecular therapy. Methods & clinical development.

Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

H. Pickett, J. Vandesompele, M. Fischer, 2020, Clinical Cancer Research.

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia.

A. Dolnikov, T. O'Brien, S. Joshi, 2015, Experimental hematology.

Targeting the immune-suppressive tumor microenvironment to potentiate CAR T cell therapy

A. Dolnikov, N. Xu, Tiffany C. Y. Tang, 2020 .

PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL Xenografts.

A. Dolnikov, T. O'Brien, D. Gottlieb, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

A. Dolnikov, M. Haber, K. Micklethwaite, 2021, ImmunoTargets and therapy.

Characterizing piggyBat—a transposase for genetic modification of T cells

B. Gloss, A. Dolnikov, K. Gowrishankar, 2022, Molecular therapy. Methods & clinical development.

LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells

Xin-Jiang Lu, Jiong Chen, Qiang Chen, 2016, Nature Communications.